X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

December 09, 2019

Evaluation of Container Systems with Residual Seal Force (RSF)

Parenteral drug products must be stored in a container system that provides good container closure integrity (CCI) over shelf life for the purpose of preventing environmental contamination. This system typically comprises a glass vial, elastomer stopper, and an aluminum seal. USP Chapter &lt;1207&gt; <em>Packaging Integrity Evaluation &ndash; Sterile Products</em> discusses in detail methods to measure CCI to determine if the system can meet the maximum allowable leak limit (MALL) for its specific drug product (i.e., the smallest gap, or leak rate, that places quality at risk). Critical to achieving good CCI is proper capping of the vial with the stopper and seal, making sure that the compression level of the stopper is appropriate.
West Pharma

Mary Tan

Specialist, Scientific Affairs, Singapore, Jurong

Previous Posts
Zwick/Roell Testing System

September 26, 2019

Performance Testing: Analysis with Zwick/Roell Testing System

Daniel Bantz

Daniel Bantz

Technical Manager, Packaging & Performance Testing

Syringes and Syringe Components

August 30, 2019

Simplify the Journey™ – Facilitating Industry Changes

Cathy Zhao

Cathy Zhao

Director, Scientific Insights Lab, SA & TS

Analytics

August 22, 2019

What’s New in the Knowledge Center? Data Analytics

Tara Haarlander

Tara Haarlander

Sr. Specialist, Scientific Communications

Load more